Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
Open Access
- 1 February 1998
- Vol. 53 (2) , 114-116
- https://doi.org/10.1136/thx.53.2.114
Abstract
Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease inhibitor found on various mucosal surfaces and has been ascribed an important role in maintaining the protease-anti-protease balance of the airways. Recent scientific evidence has suggested that SLPI may also have a broad spectrum antibiotic activity that includes antiretroviral, bactericidal, and antifungal activity. Given the unpropitious development of drug resistance to infectious micro-organisms in the human population, the need for therapeutic alternatives in the treatment of infectious diseases has become clear. SLPI may prove valuable in the prophylaxis and future treatment of infectious diseases, yet the clinical efficacy of SLPI remains largely to be elucidated.Keywords
This publication has 15 references indexed in Scilit:
- Proteases fromAspergillus fumigatusInduce Release of Proinflammatory Cytokines and Cell Detachment in Airway Epithelial Cell LinesThe Journal of Infectious Diseases, 1997
- Somatic Mutations in Paroxysmal Nocturnal Hemoglobinuria: A Blessing in Disguise?Cell, 1997
- Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.Thorax, 1996
- Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitorAntiviral Research, 1996
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic FibrosisAmerican Review of Respiratory Disease, 1993
- Inhibition of Lipopolysaccharide-induced Pulmonary Emphysema by Intratracheally Instilled Recombinant Secretory Leukocyte Proteinase InhibitorAmerican Review of Respiratory Disease, 1993
- Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.Journal of Clinical Investigation, 1992
- Different Susceptibility of Elastase Inhibitors to Inactivation by Proteinases fromStaphylococcus aureusandPseudomonas aeruginosaBiological Chemistry Hoppe-Seyler, 1991
- Antileukoprotease in Sputum during Bronchial InfectionsChest, 1986